Geraldine Henwood

Affiliations

  • President And Ceo at Baudax Bio Inc. (BXRX), 2022-12-19
  • Director at Recro Pharma Inc. (REPH), 2021-05-17
  • Director at Tetraphase Pharmaceuticals Inc (TTPH), 2019-06-11
  • Director at Alkermes Plc. (ALKS), 2014-05-30
  • Director at Map Pharmaceuticals Inc. (MAPP), 2013-03-05
  • Director at Alkermes Inc (ALKS), 2011-09-20
Insider Trading: Purchases See All
Symbol Price Amount Total Value Remaining Holdings Date Form 4
BXRX $2.55 1,200 $3,057.12 2,427 2022-12-15 Filing
BXRX $0.59 8,200 $4,797.82 364,507 2021-09-22 Filing
BXRX $0.83 6,000 $4,992.00 356,307 2021-05-07 Filing
REPH $9.56 550 $5,258.00 104,500 2015-06-08 Filing
REPH $8.83 3,950 $34,878.50 103,950 2015-06-05 Filing
Insider Trading: Sales See All
Symbol Price Amount Total Value Remaining Holdings Date Form 4
REPH $8.22 80,000 $657,600.00 241,194 2020-04-17 Filing
REPH $8.22 80,000 $657,600.00 161,194 2020-04-17 Filing
REPH $8.89 21,306 $189,380.51 198,141 2019-05-13 Filing
REPH $8.89 123,500 $1,097,915.00 219,447 2019-05-13 Filing
ALKS $48.28 2,400 $115,878.00 0 2014-01-15 Filing